Vanguard Fiduciary Trust
OVID icon

Vanguard Fiduciary Trust’s Ovid Therapeutics OVID Stock Holding History

Vanguard Fiduciary Trust’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Buy
1,140,753
+447,497
+65% +$1.15M ﹤0.01% 2449
2026
Q1 		$1.54M Buy
+693,256
New +$1.24M ﹤0.01% 2704

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Fiduciary Trust's OVID Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Ovid Therapeutics (OVID) stake by 65% in Q2 2026, buying an estimated $1.15M and bringing the position to 1,140,753 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Vanguard Fiduciary Trust first reported a position in OVID in Q1 2026 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,140,753 shares of Ovid Therapeutics worth $3.07M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 447,497 Ovid Therapeutics shares in Q2 2026, an estimated $1.15M.
  • Ovid Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2449 holding.
  • Vanguard Fiduciary Trust first reported a position in Ovid Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.